|
Market Cap (5-Jun) $35,464,388 (1,259th) |
Close (30-Jun) $0.080 |
Volume (30-Jun) 244,049 |
Shortsold (15-Jan) 38,875 (0.01%) (540th) |
|
52w High $0.260 |
52w Low $0.054 |
P/E - |
EPS -0.02 |
NSB released this announcement to the ASX on 28 June 2021, 16:58. The announcement is not marked as price sensitive, and is 2 page(s) in length and 230.76kb in size.
You can view all announcements from NSB and see how they appear on a price chart on the announcements page.
At the date of this announcement, NSB was 0.013% short sold according to ASIC data. It was ranked the 584th most shorted stock on the ASX. It is now ranked as the 540th most shorted stock on the ASX with 0.012% of total shares short sold as of the latest reported data (15 January 2026).
| Other Recent Announcements from NSB | |
|---|---|
| Change of Director's Interest Notice - Rennie | 7 June 2023, 8:22 |
| Change of Director's Interest Notice - Uvarov | 25 May 2023, 15:30 |
| Change of Director's Interest Notice - Rennie | 25 May 2023, 15:07 |
| Initial Director's Interest Notice | 28 June 2021, 16:58 |
| Gold Coast Investment Showcase Presentation | 23 June 2021, 12:50 |
| NSB partners with Linear Research for Phase I Clinical Study | 23 June 2021, 8:18 |
| Proposed issue of securities - NSB | 22 June 2021, 16:31 |
You must be logged in to post a reply.
NeuroScientific Biopharmaceuticals 